Simple obesity
Conditions
Interventions
Acupoint Embedding Combined with Spleen-Strengthening and Fat-Dissolving Formula Group:Acupoint Embedding Combined with Spleen-Strengthening and Fat-Reducing Prescription
Acupuncture Point Implantation Set:Acupoint embedding
Sponsors
Shandong Provincial Third Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: 1. Meets diagnostic criteria and pattern differentiation standards; 2. Aged 18–59 years, no gender restrictions; 3. No other endocrine or metabolic disorders; 4. No relevant treatment received within 3 months prior to enrolment; 5. Good compliance with treatment and follow-up appointments as required; 6. Voluntary participation in the trial and signing of informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who have taken any weight-loss medication or undergone any other weight-loss treatment within the past three months; 2. Pregnant or breastfeeding women; 3. Individuals with allergies to foreign proteins or a tendency to develop keloid scars; 4. Patients with diabetes, significant organic diseases affecting the heart, brain, liver, or kidneys, infectious diseases, or haematological disorders; 5. Secondary obesity (diagnosed pituitary disorders, hypothalamic disorders, pancreatic disorders, hypothyroidism, hypogonadism, hyperadrenocorticism, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemistry: blood lipids (HDL-C, TG, TC, LDL-C), blood glucose metabolism indicators (FBG, FINS), BUA, and liver function (ALT, AST);Body Composition ;Inflammation and Hormone Indicators:LeptinIL-6TNF-a;Traditional Chinese Medicine Syndrome Scoring;Gut microbiota; | — |
Countries
China
Contacts
Public ContactBai tianyu
Shandong Provincial Third Hospital
Outcome results
None listed